发明名称 NOVEL PROPENOHYDROXAMIC ACID DERIVATIVES
摘要 <p>Propenohydroxamic acid derivatives represented by the following general formula (1) or salts thereof and drugs containing the same: (1) wherein R1 represents hydrogen, alkyl or halogeno; R2 represents cycloalkyl, aryl, heteroaryl, etc.; R3 represents hydrogen, alkenyl, etc.; R5 represents R6CO- , R6SO2-, R6NHCO- or R6NHCS- (wherein R6 represents alkyl, cycloalkyl, cyclic amino, aryl, heteroaryl, etc.); R7 represents hydrogen or a protective group ; and A represents CH, nitrogen or oxidized nitrogen. Because of having an excellent TACE inhibitory activity, the above compounds are useful as drugs for preventing and/or treating diseases such as sepsis, rheumatoid arthritis , arthritis deformans, infectious diseases, autoimmune diseases, malignant neoplasm, collagen disease, ulcerative colitis, MOF, non-insulin-dependent diabetes mellitus, etc.</p>
申请公布号 CA2423733(A1) 申请公布日期 2003.02.14
申请号 CA20012423733 申请日期 2001.08.27
申请人 WAKUNAGA PHARMACEUTICAL CO., LTD. 发明人 ITO, KENJI;KATAYAMA, KIMIKO;INOKUMA, KENICHI;HIRATA, TERUKAGE;MISUMI, KEIJI
分类号 A61K31/17;A61K31/18;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4453;A61K31/47;A61P1/04;A61P3/10;A61P19/02;A61P29/00;A61P31/04;A61P35/00;A61P37/06;A61P43/00;C07C259/06;C07C275/34;C07C275/42;C07C311/08;C07C311/13;C07C311/21;C07C311/29;C07C311/44;C07C311/46;C07C335/22;C07D213/55;C07D213/56;C07D213/89;C07D215/36;C07D241/12;C07D295/26;(IPC1-7):C07C259/06;C07D295/22;A61K31/445;C07D213/74;A61K31/440 主分类号 A61K31/17
代理机构 代理人
主权项
地址